The list of Belarusian (Russian) manufactured medicinal products mandatory for pharmacies of all ownership forms to stock has been updated in Belarus, BELTA reports, citing the National Legal Internet Portal of Belarus.
The list has been established by the Ministry of Health's Resolution No. 92 dated December 10, 2018. It includes over 240 medicinal product names.
For the digestive tract and metabolism, the list includes, in particular, "Omeprazole", "Drotaverine", "Spasmaton", "Nifuroxazide", "Loperamide"; for the cardiovascular system - "Glyceryl trinitrate", "Validol", "Furosemide", "Heparin"; for the musculoskeletal system - "Glucosamine", "Ibuprofen", "Nimesulide", "Ketorolac"; for the nervous system - "Lidocaine", "Angrimax", "Paracetamol", "Citramon-Borimed", "Vinpocetine", "Piracetam", "Glycine".
Dermatological agents listed include "Miconazole", "Nystatin", "Methyluracil"; agents for treating sensory organ diseases include eye drops "Levofloxacin", "Diclofenac", "Artificial Tear"; antineoplastic and immunomodulatory agents include "Interferon alfa-2b". As for respiratory system medicinal products, these include, in particular, "Oxymetazoline", "Rhinocil", "Ambroxol", "Loratadine".
The document comes into force one month after its official publication.
Resolution of the Ministry of Health No. 84 dated August 28, 2017 "On establishing the list of Belarusian (Russian) manufactured medicinal products mandatory for pharmacies of all ownership forms engaged in retail sale of medicinal products" has been declared invalid.